Hempsana Holdings Past Earnings Performance
Past criteria checks 0/6
Hempsana Holdings has been growing earnings at an average annual rate of 4.8%, while the Pharmaceuticals industry saw earnings growing at 59.3% annually. Revenues have been growing at an average rate of 102.8% per year.
Key information
4.8%
Earnings growth rate
17.9%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | 102.8% |
| Return on equity | -273.8% |
| Net Margin | -94.1% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Hempsana Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 2 | -1 | 2 | 0 |
| 30 Jun 23 | 2 | -1 | 2 | 0 |
| 31 Mar 23 | 1 | -2 | 2 | 0 |
| 31 Dec 22 | 1 | -1 | 2 | 0 |
| 30 Sep 22 | 1 | -2 | 2 | 0 |
| 30 Jun 22 | 1 | -4 | 2 | 0 |
| 31 Mar 22 | 0 | -4 | 2 | 0 |
| 31 Dec 21 | 0 | -4 | 2 | 0 |
| 30 Sep 21 | 0 | -5 | 2 | 0 |
| 30 Jun 21 | 0 | -2 | 2 | 0 |
| 31 Mar 21 | 0 | -2 | 2 | 0 |
| 31 Dec 20 | 0 | -2 | 1 | 0 |
Quality Earnings: HMPS is currently unprofitable.
Growing Profit Margin: HMPS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HMPS is unprofitable, but has reduced losses over the past 5 years at a rate of 4.8% per year.
Accelerating Growth: Unable to compare HMPS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HMPS is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (11.7%).
Return on Equity
High ROE: HMPS has a negative Return on Equity (-273.76%), as it is currently unprofitable.